Tissue-engineered gut-sphincter complexes and methods of making the same

Patent metadata

Field	Value
Publication number	US-11311367-B2
Application number	US-202017066233-A
Country	US
Kind code	B2
Filing date	Oct 8, 2020
Priority date	Jan 31, 2012
Publication date	Apr 26, 2022
Grant date	Apr 26, 2022

Abstract

Methods are disclosed for forming tissue engineered, tubular gut-sphincter complexes from intestinal circular smooth muscle cells, sphincteric smooth muscle cells and enteric neural progenitor cells. The intestinal smooth muscle cells and neural progenitor cells can be seeded on a mold with a surface texture that induces longitudinal alignment of the intestinal smooth muscle cells and co-cultured until an innervated aligned smooth muscle sheet is obtained. The innervated smooth muscle sheet can then be wrapped around a tubular scaffold to form an intestinal tissue construct. Additionally, the sphincteric smooth muscle cells and additional enteric neural progenitor cells can be mixed in a biocompatiable gel solution, and the gel and admixed cells applied to a mold having a central post such that the sphinteric smooth muscle and neural progenitor cells can be cultured to form an innervated sphincter construct around the mold post. This innervated sphincter construct can also be transferred to the tubular scaffold such that the intestinal tissue construct and sphincter construct contact each other, and the resulting combined sphincter and intestinal tissue constructs can be further cultured about the scaffold until a unified tubular gut-sphincter complex is obtained.

First claim

The invention claimed is:

1. A method of forming a tissue engineered, tubular gut-sphincter complex comprising:
isolating intestinal circular smooth muscle cells from an intestinal donor source,
isolating sphincteric smooth muscle cells from a sphincteric donor source,
isolating enteric neural progenitor cells from at least one neural progenitor donor source,
seeding the isolated intestinal circular smooth muscle cells on a mold with a surface texture that induces longitudinal alignment of the intestinal circular smooth muscle cells,
adding the isolated enteric neural progenitor cells to the intestinal circular smooth muscle cells on the mold,
co-culturing the intestinal circular smooth muscle cells and the enteric neural progenitor cells until an innervated aligned smooth muscle sheet is obtained,
disposing the innervated aligned smooth muscle sheet around a tubular scaffold to form an innervated intestinal tissue construct,
admixing the sphincteric smooth muscle cells and additional enteric neural progenitor cells in a biocompatible gel solution,
applying the gel and admixed cells to a mold having a central post;
co-culturing the sphincteric smooth muscle cells and neural progenitor cells to form an innervated sphincter construct around the mold post,
transferring and applying the innervated sphincter construct to the tubular scaffold such that the innervated intestinal tissue construct and the innervated sphincter construct contact each other, and
further culturing the combined sphincter and intestinal tissue constructs about the scaffold until a unified tubular gut-sphincter complex is obtained.

2. The method of claim 1 , wherein steps of isolating the intestinal circular smooth muscle cells, sphincteric smooth muscle cells and enteric neural progenitor cells further comprise obtaining each type of cell from a single subject.

3. The method of claim 1 , wherein at least one co-culturing step comprises culturing cells in a collagen suspension.

4. The method of claim 1 , wherein the step of disposing the innervated aligned smooth muscle sheet around a tubular scaffold comprises wrapping the innervated aligned smooth muscle sheet around a chitosan scaffold.

5. The method of claim 1 , wherein the method further comprises connecting two or more innervated aligned smooth muscle sheets together to form a composite structure.

6. A tubular gut-sphincter complex formed by the method of claim 1 .

Assignees

• Univ Wake Forest Health Sciences

Inventors

• Bitar Khalil

Classifications

• C12N2501/115

  Basic fibroblast growth factor (bFGF, FGF-2) · CPC title

• C12N5/0697

  Artificial constructs associating cells of different lineages, e.g. tissue equivalents (blood vessels C12N5/0691) · CPC title

• C12N2501/11

  Epidermal growth factor [EGF] · CPC title

• A61K35/34

  Muscles; Smooth muscle cells; Heart; Cardiac stem cells; Myoblasts; Myocytes; Cardiomyocytes (vascular smooth muscle A61K35/44) · CPC title

• A61L27/3886

  comprising two or more cell types · CPC title